small molecule

BETAMETHASONE DIPROPIONATE

Loss of exclusivity—loss of exclusivity

CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand name	BETAMETHASONE DIPROPIONATE
Active ingredient	BETAMETHASONE DIPROPIONATE
Strength	EQ 0.05% BASE
Dosage form	OINTMENT, AUGMENTED
Route	TOPICAL
Modality	Small molecule
FDA approval	December 2019
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.